Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)

J. I. Meesters-Ensing; R. Admiraal; L. Ebskamp; A. Lacna; J. J. Boelens; C. A. Lindemans; S. Nierkens

doi:10.3389/fphar.2024.1444228

Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)

J. I. Meesters-Ensing, R. Admiraal^*, L. Ebskamp, A. Lacna, J. J. Boelens, C. A. Lindemans, S. Nierkens

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

In the published article, there was an error. The unit of AUC used throughout the paper is incorrect. A correction has been made to the sections “Patients eligible for TDM and simulation for the calculated optimal dose,” (paragraph 3) “Therapeutic drug monitoring” (paragraph 2) and to the footnotes of Table 1. The unit for AUC previously stated: “AU*day/L” The corrected unit for AUC appears below: “AU*day/mL” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	1444228
Journal	Frontiers in Pharmacology
Volume	15
DOIs	https://doi.org/10.3389/fphar.2024.1444228
Publication status	Published - 6 Aug 2024

Keywords

anti-thymocyte globulin (ATG)
antibody
pediatrics-children
stem cell transplant (SCT)
TDM (therapeutic drug monitoring)

Access to Document

10.3389/fphar.2024.1444228Licence: CC BY

fphar-15-1444228Final published version, 485 KBLicence: CC BY

Cite this

Meesters-Ensing, J. I., Admiraal, R., Ebskamp, L., Lacna, A., Boelens, J. J., Lindemans, C. A., & Nierkens, S. (2024). Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094). Frontiers in Pharmacology, 15, Article 1444228. https://doi.org/10.3389/fphar.2024.1444228

@article{45ba47dde54b4882a83dc9204fbc1e32,

title = "Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)",

abstract = "In the published article, there was an error. The unit of AUC used throughout the paper is incorrect. A correction has been made to the sections “Patients eligible for TDM and simulation for the calculated optimal dose,” (paragraph 3) “Therapeutic drug monitoring” (paragraph 2) and to the footnotes of Table 1. The unit for AUC previously stated: “AU*day/L” The corrected unit for AUC appears below: “AU*day/mL” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "anti-thymocyte globulin (ATG), antibody, pediatrics-children, stem cell transplant (SCT), TDM (therapeutic drug monitoring)",

author = "Meesters-Ensing, {J. I.} and R. Admiraal and L. Ebskamp and A. Lacna and Boelens, {J. J.} and Lindemans, {C. A.} and S. Nierkens",

note = "Publisher Copyright: Copyright {\textcopyright} 2024 Meesters-Ensing, Admiraal, Ebskamp, Lacna, Boelens, Lindemans and Nierkens.",

year = "2024",

month = aug,

day = "6",

doi = "10.3389/fphar.2024.1444228",

language = "English",

volume = "15",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media S. A.",

}

Meesters-Ensing, JI, Admiraal, R, Ebskamp, L, Lacna, A, Boelens, JJ, Lindemans, CA & Nierkens, S 2024, 'Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)', Frontiers in Pharmacology, vol. 15, 1444228. https://doi.org/10.3389/fphar.2024.1444228

Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094). / Meesters-Ensing, J. I.; Admiraal, R.; Ebskamp, L. et al.
In: Frontiers in Pharmacology, Vol. 15, 1444228, 06.08.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Corrigendum

T2 - Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)

AU - Meesters-Ensing, J. I.

AU - Admiraal, R.

AU - Ebskamp, L.

AU - Lacna, A.

AU - Boelens, J. J.

AU - Lindemans, C. A.

AU - Nierkens, S.

PY - 2024/8/6

Y1 - 2024/8/6

N2 - In the published article, there was an error. The unit of AUC used throughout the paper is incorrect. A correction has been made to the sections “Patients eligible for TDM and simulation for the calculated optimal dose,” (paragraph 3) “Therapeutic drug monitoring” (paragraph 2) and to the footnotes of Table 1. The unit for AUC previously stated: “AU*day/L” The corrected unit for AUC appears below: “AU*day/mL” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the published article, there was an error. The unit of AUC used throughout the paper is incorrect. A correction has been made to the sections “Patients eligible for TDM and simulation for the calculated optimal dose,” (paragraph 3) “Therapeutic drug monitoring” (paragraph 2) and to the footnotes of Table 1. The unit for AUC previously stated: “AU*day/L” The corrected unit for AUC appears below: “AU*day/mL” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - anti-thymocyte globulin (ATG)

KW - antibody

KW - pediatrics-children

KW - stem cell transplant (SCT)

KW - TDM (therapeutic drug monitoring)

UR - http://www.scopus.com/inward/record.url?scp=85201964711&partnerID=8YFLogxK

U2 - 10.3389/fphar.2024.1444228

DO - 10.3389/fphar.2024.1444228

M3 - Comment/Letter to the editor

AN - SCOPUS:85201964711

SN - 1663-9812

VL - 15

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1444228

ER -

Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept

Cite this